Sheel Biotech Ltd.

Insufficient data

FAQs on Sheel Biotech Ltd. Shareprice

Has the share price of Sheel Biotech grown faster than its competition?

There is not enough historical data for the companies share price.

Is Sheel Biotech stock expensive?

There is insufficient historical data to gauge this.
Latest PE of Sheel Biotech is 0

View FAQ's On Business

Reverse DCF

Earnings

Discount Rate (%)

Terminal Multiple

5 YEAR

10 YEAR

20 YEAR

Implied Growth Rate over a 5 year period*

Implied Growth Rate over a 10 year period*

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Raphson method.

Learn how to use Reverse DCF

FAQs on Sheel Biotech Ltd. Financials

How strong is Sheel Biotech balance sheet?

Sheel Biotech balance sheet is weak and might have solvency issues

Is the debt of Sheel Biotech increasing or decreasing?

The net debt of Sheel Biotech is decreasing.
Latest net debt of Sheel Biotech is ₹16.52 Crs as of Mar-25.
This is less than Mar-24 when it was ₹22.44 Crs.

Is the profitablity of Sheel Biotech improving?

Yes, profit is increasing.
The profit of Sheel Biotech is ₹10.64 Crs for Mar 2025, ₹10.47 Crs for Mar 2024 and ₹5.08 Crs for Mar 2023

Does Sheel Biotech pay decent dividends?

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sheel Biotech latest dividend payout ratio is 14.06% and 3yr average dividend payout ratio is 17.21%

How has Sheel Biotech allocated its funds?

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding